Organization | Truman Medical Center

Truman Medical Center Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2009

NCT00547716

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Harry S. Truman Memorial, Columbia, MO | Truman Medical Center

Active Ingredients

Drugs in Phase 4 Trials (1)

bupivacaine (Exparel) (1 trial)

Drugs in Other Trials (5)

heparin (liquaemin) (1 trial)

icosapent ethyl (vascepa) (1 trial)

metilcelulosa (1 trial)

sodium chloride (1 trial)

timolol (blocadren) (1 trial)

Indications

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 6